Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3206]

$ASH 2018: Alvocidib shows encouraging activity in patients with MCL-1 dependent relapsed or refractory AML$

ASH 2018: Alvocidib shows encouraging activity in patients with MCL-1 dependent relapsed or refractory AML

Sugar supplement slows tumor growth and can improve cancer treatment

Sugar supplement slows tumor growth and can improve cancer treatment

New mechanism controlling the master cancer regulator uncovered

New mechanism controlling the master cancer regulator uncovered

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no...

Solving the mystery of NPM1 in acute myeloid leukaemia

Solving the mystery of NPM1 in acute myeloid leukaemia

Small populations of normal cells affect immunity in patients with XLP1

Small populations of normal cells affect immunity in patients with XLP1

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

Targeted radiation provides option for kids with difficult-to-treat liver cancer

Targeted radiation provides option for kids with difficult-to-treat liver cancer

Researchers have unlocked secrets about engineered protein receptor CAR

Researchers have unlocked secrets about engineered protein receptor CAR

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

More from ecancer